Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy

被引：0
|
作者：
Terzic, T.
Teira, P.
Cournoyer, S.
Peuchmaur, M.
Sartelet, H.
机构：
[1] Ctr Hosp Univ St Justine, Montreal, PQ, Canada
[2] Hop Univ Robert Debre, Paris, France
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1869
引用
收藏
页码：449A / 449A
页数：1
相关论文
共 50 条
  • [31] Naxitamab, An Antibody With Distinct Complementary Determining Regions and High Binding Affinity to Disialoganglioside GD2
    Lisby, S.
    Liebenberg, N.
    Bukrinski, J.
    Sonderby, P.
    Lund-Hansen, T.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S281 - S282
  • [32] Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2
    Foon, KA
    Lutzky, J
    Baral, RN
    Yannelli, JR
    Hutchins, L
    Teitelbaum, A
    Kashala, OL
    Das, R
    Garrison, J
    Reisfeld, RA
    Bhattacharya-Chatterjee, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 376 - 384
  • [33] Structure based refinement of a humanized monoclonal antibody that targets tumor antigen disialoganglioside GD2
    Ahmed, Mahiuddin
    Hu, Jian
    Cheung, Nai-Kong V.
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [34] The expression of gangliosides GD2 is associated with worse prognosis in melanoma patients
    Kong, Yan
    Yu, Jiayi
    Si, Lu
    Chi, Zhihong
    Cui, Chuanliang
    Sheng, Xinan
    Guo, Jun
    CANCER RESEARCH, 2016, 76
  • [35] Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
    Poon, Vincent I.
    Roth, Michael
    Piperdi, Sajida
    Geller, David
    Gill, Jonathan
    Rudzinski, Erin R.
    Hawkins, Douglas S.
    Gorlick, Richard
    CLINICAL SARCOMA RESEARCH, 2015, 5
  • [36] GANGLIOSIDE GD2 EXPRESSION IS MAINTAINED UPON RECURRENCE IN PATIENTS WITH OSTEOSARCOMA
    Poon, V., I
    Roth, M.
    Piperdi, S.
    Geller, D.
    Gill, J.
    Ridzinski, E. R.
    Hawkins, D. S.
    Gorlick, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (01) : 201 - 201
  • [37] GD2 expression in Merkel cell carcinoma
    Orouji, A.
    Orouji, E.
    Ludwig-Peitsch, W.
    Goerdt, S.
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 55 - 56
  • [38] Frequency of ALK and GD2 Expression in Neuroblastoma
    Aygun, Zeynep
    Batur, Sebnem
    Emre, Senol
    Celkan, Tiraje
    Ozman, Oktay
    Comunoglu, Nil
    FETAL AND PEDIATRIC PATHOLOGY, 2019, 38 (04) : 326 - 334
  • [39] Differential expression of the gangliosides GD3 and GD2 in canine and human osteosarcoma cell lines: An immunotherapy target
    Milner, Rowan J.
    Chimura, Noaki
    Bowles, Kristina D.
    Salute, Marc
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [40] Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
    Reppel, Loic
    Tsahouridis, Ourania
    Akulian, Jason
    Davis, Ian J.
    Lee, Hong
    Fuca, Giovanni
    Weiss, Jared
    Dotti, Gianpietro
    Pecot, Chad, V
    Savoldo, Barbara
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
12345